Clinical efficacy and determinants of response to treatment with desmopressin in mild hemophilia A

Seminars in Thrombosis and Hemostasis

Volumn 39, Issue 7, 2013, Pages 732-739

  Di Perna, Caterina ^a   Riccardi, Federica ^a   Franchini, Massimo ^b   Rivolta, Giannafranca ^a   Pattacini, Corrado ^a   Tagliaferri, Annarita ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b CARLO POMA HOSPITAL   (Italy)

Author keywords

desmopressin; genotype; mild hemophilia A; treatment efficacy

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; DESMOPRESSIN; TRANEXAMIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CHILD; CLINICAL EFFECTIVENESS; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG SAFETY; FACE FLUSHING; FOLLOW UP; GENE DUPLICATION; GENETIC ANALYSIS; HEART RATE; HEMOPHILIA A; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROPHYLAXIS; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DEAMINO ARGININE VASOPRESSIN; HEMOPHILIA A; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84885077540     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1354418     Document Type: Article

References (34)

1. Mannucci P. M., Tuddenham E. GD. The hemophilias-from royal genes to gene therapy. N Engl J Med: 2001; 344 23 1773 1779 (Pubitemid 32497033)
2. Bolton-Maggs P. H., Pasi K. J. Haemophilias A and B. Lancet: 2003; 361 9371 1801 1809 (Pubitemid 36638432)
3. Hoyer L. W. Hemophilia A. N Engl J Med: 1994; 330 1 38 47 (Pubitemid 24018616)
4. Franchini M., Mannucci P. M. Past, present and future of hemophilia: a narrative review. Orphanet J Rare Dis: 2012; 7 24
5. White G. C. II, Rosendaal F., Aledort L. M., Lusher J. M., Rothschild C., Ingerslev J.; Factor VIII and Factor IX Subcommittee. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost: 2001; 85 3 560 (Pubitemid 32233035)
6. Franchini M., Favaloro E. J., Lippi G. Mild hemophilia A. J Thromb Haemost: 2010; 8 3 421 432
7. Franchini M. The use of desmopressin as a hemostatic agent: a concise review. Am J Hematol: 2007; 82 8 731 735 (Pubitemid 47221656)
8. Franchini M., Zaffanello M., Lippi G. The use of desmopressin in mild hemophilia A. Blood Coagul Fibrinolysis: 2010; 21 7 615 619
9. Mannucci P. M. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years. Haemophilia: 2000; 6 01 60 67 (Pubitemid 30468295)
10. Castaman G. Desmopressin for the treatment of haemophilia. Haemophilia: 2008; 14 01 15 20
11. Riccardi F., Rivolta G. F., Franchini M., Pattacini C., Neri T. M., Tagliaferri A. Characterization of a novel mutation in the F8 promoter region associated with mild hemophilia A and resistance to DDAVP therapy. J Thromb Haemost: 2009; 7 7 1234 1235
12. Castaman G., Mancuso M. E., Giacomelli S. H., et al. Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A. J Thromb Haemost: 2009; 7 11 1824 1831
13. Tagliaferri A., Di Perna C., Riccardi F., Pattacini C., Rivolta G. F., Franchini M. The natural history of mild haemophilia: a 30-year single centre experience. Haemophilia: 2012; 18 2 166 174
14. Tagliaferri A., Rivolta G. F., Biasoli C., et al. A web-based registry of inherited bleeding disorders in the region of Emilia-Romagna: results at three and a half years. Haemophilia: 2008; 14 2 343 354 (Pubitemid 351338696)
15. Pattacini C., Rivolta G. F., Di Perna C., Riccardi F., Tagliaferri A.; Haemophilia Centres Network of Emilia-Romagna Region. A web-based clinical record 'xl'Emofilia' for outpatients with haemophilia and allied disorders in the Region of Emilia-Romagna: features and pilot use. Haemophilia: 2009; 15 1 150 158
16. Williams I. J., Abuzenadah A., Winship P. R., et al. Precise carrier diagnosis in families with haemophilia A: use of conformation sensitive gel electrophoresis for mutation screening and polymorphism analysis. Thromb Haemost: 1998; 79 4 723 726 (Pubitemid 28163842)
17. Oldenburg J., Ivaskevicius V., Rost S., et al. Evaluation of DHPLC in the analysis of hemophilia A. J Biochem Biophys Methods: 2001; 47 1-2 39 51 (Pubitemid 32155474)
18. Xiao W., Oefner P. J. Denaturing high-performance liquid chromatography: A review. Hum Mutat: 2001; 17 6 439 474 (Pubitemid 32480082)
19. Acquila M., Pasino M., Lanza T., Bottini F., Molinari A. C., Bicocchi M. P. Duplication of exon 13 causes one third of the cases of mild hemophilia A in northern Italy. Haematologica: 2004; 89 6 758 759 (Pubitemid 38828489)
20. Oldenburg J., El-Maarri O., Schwaab R. Inhibitor development in correlation to factor VIII genotypes. Haemophilia: 2002; 8 02 23 29 (Pubitemid 34506224)
21. Stoof S. C., Sanders Y. V., Petrij F., et al. Response to desmopressin is strongly dependent on F8 gene mutation type in mild and moderate haemophilia A. Thromb Haemost: 2013; 109 3 440 449
22. Mannucci P. M., Ruggeri Z. M., Pareti F. I., Capitanio A. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet: 1977; 1 8017 869 872 (Pubitemid 8079684)
23. Franchini M. The modern treatment of haemophilia: a narrative review. Blood Transfus: 2013; 11 2 178 182
24. Lethagen S. Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety. Semin Thromb Hemost: 2003; 29 1 101 106
25. Peerlinck K., Jacquemin M. Mild haemophilia: a disease with many faces and many unexpected pitfalls. Haemophilia: 2010; 16 05 100 106
26. Nolan B., White B., Smith J., O'Reily C., Fitzpatrick B., Smith O. P. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders. Br J Haematol: 2000; 109 4 865 869 (Pubitemid 30609770)
27. Revel-Vilk S., Blanchette V. S., Sparling C., Stain A. M., Carcao M. D. DDAVP challenge tests in boys with mild/moderate haemophilia A. Br J Haematol: 2002; 117 4 947 951 (Pubitemid 34639260)
28. Seary M. E., Feldman D., Carcao M. D. DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype. Haemophilia: 2012; 18 1 50 55
29. Knöfler R., Koscielny J., Tauer J. T., et al. Desmopressin testing in haemophilia A patients and carriers: results of a multi centre survey. Hamostaseologie: 2012; 32 4 271 275
30. Zimmermann M. A., Meier D., Oldenburg J., Müller C. R., Rost S. Identification and characterization of mutations in the promoter region of the factor VIII gene. J Thromb Haemost: 2012; 10 2 314 317
31. Rodeghiero F., Castaman G., Mannucci P. M. Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A. Thromb Haemost: 1996; 76 5 692 696 (Pubitemid 26388171)
32. de la Fuente B., Kasper C. K., Rickles F. R., Hoyer L. W. Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin. Ann Intern Med: 1985; 103 1 6 14 (Pubitemid 15068491)
33. Ghirardini A., Chistolini A., Tirindelli M. C., et al. Clinical evaluation of subcutaneously administered DDAVP. Thromb Res: 1988; 49 3 363 372
34. Web-based Registry of Inherited Bleeding Disorders in the Region Emilia-Romagna. Available at: http//www.registroemofiliarer.it. Accessed April 24, 2013